middle.news
Cencora’s oncology push powers a new fiscal 2027 growth outlook
10:37pm on Wednesday 4th of November, 2026 AEDT
•
Healthcare
Read Story
Cencora’s oncology push powers a new fiscal 2027 growth outlook
10:37pm on Wednesday 4th of November, 2026 AEDT
Key Points
Fiscal 2026 revenue rose 5.0% to US$337.4 billion
Fourth-quarter adjusted diluted EPS increased 21.4% to US$4.66
Fiscal 2027 adjusted EPS guidance is US$19.40 to US$19.75
Quarterly dividend lifted 10% to US$0.66 per share
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cencora (NYSE:COR)
OPEN ARTICLE